ArticleOncotarget2017
Biomarker analysis of the phase 3 TORCH trial for first line erlotinib
Lucia Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it
ArticleOncotarget2017
Lucia Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.